An independent practice association-supported disease management program: Impact on patients with coronary artery disease

Disease Management and Health Outcomes

Volumn 10, Issue 9, 2002, Pages 571-577

  Cannon Wagner, Miriam ^a   Soule, Diane S ^a   Walker, David R ^a   Vance, Richard P ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADULT; AGED; ARTICLE; CORONARY ARTERY DISEASE; FEMALE; HEALTH CARE PLANNING; HEALTH CARE UTILIZATION; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; MORBIDITY; OUTCOMES RESEARCH; PATIENT EDUCATION; PRACTICE GUIDELINE; QUALITY OF LIFE; SCORING SYSTEM; SEX DIFFERENCE; STATISTICAL ANALYSIS; UNITED STATES;

EID: 0036046229     PISSN: 11738790     EISSN: None     Source Type: Journal    
DOI: 10.2165/00115677-200210090-00005     Document Type: Article

References (28)

1. Primary care physician incentives in medical group practices
2. Independent physician associations (IPA' s): Regaining control of managed care
3. Models of managed care: The potential power of the IPA
4. Consolidation of medical groups into physician practice management organizations
5. The independent practice association in theory and practice: Lessons from experience
6. Physician organization in California: Crisis and opportunity
7. Unlike hospitals, IPAs still rely heavily on capitation revenue
8. IPAs improve utilization control with blended RVU/Contract cap plan
9. Executive summary of the third report of the national Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults. Adult Treatment Panel IIL
10. The disease management boom: How doctors are dealing with it
11. Here's what's coming -like it or not: Doctors' reluctance to follow disease management guidelines, includes related article on independent practice associations
12. 1999 Update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)
13. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: Executive summary and recommendations. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Unstable Angina)
14. Analyzing variations in medication compliance related to individual drug class, and prescribing physician
15. Counseling in special populations: The elderly patient
16. The role of medication noncompliance and adverse reactions in hospitalizations of the elderly
17. Assessing compliance to antihypertensive medications using computer-based pharmacy records
18. Mis-medication and under utilization of aspirin in the prevention and treatment of cardiovascular disease
19. Poor adherence with hypolipidemic drugs: A lost opportunity
20. Patient-reported frequency of taking aspirin in a population with coronary artery disease
21. Underuse of aspirin in a referral population with documented coronary artery disease
22. Changes in rates of beta-blocker use between 1994 and 1997 among elderly survivors of acute myocardial infarction